Understanding how circadian rhythms affect alcohol-related organ damage
Center for Circadian Rhythms and Alcohol-Induced Tissue Damage
This study is looking at how our body clocks might affect the risk of organ damage in people who struggle with alcohol use, to help understand why some folks get hurt more than others, and it’s also here to support researchers who want to learn more about this important topic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rush University Medical Center NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11014799 on NIH RePORTER |
What this research studies
This research investigates the relationship between circadian rhythms and the risk of organ damage in individuals with alcohol use disorders. It aims to identify why some people develop significant organ damage while others do not, focusing on the role of disrupted circadian homeostasis. The project will provide resources and support for researchers studying these interactions, including training for junior investigators. By combining expertise in circadian biology and alcohol research, the center seeks to advance knowledge in this critical area.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with alcohol use disorders who may be at risk for organ damage.
Not a fit: Patients who do not have an alcohol use disorder or those without any risk factors for organ damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for organ damage in individuals with alcohol use disorders.
How similar studies have performed: Previous research has shown promising results in understanding the impact of circadian rhythms on various health conditions, suggesting potential for success in this novel approach.
Where this research is happening
Chicago, United States
- Rush University Medical Center — Chicago, United States (Active)
Researchers
- Principal investigator: Keshavarzian, Ali — Rush University Medical Center
- Study coordinator: Keshavarzian, Ali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.